Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Leiomyoma × Tranexamic Acid × Clear all

Phase

Status

Completed 3 Unknown 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Bone Neoplasms 2 Skin Neoplasms 1 Sarcoma 1 Leiomyoma 1 Hemorrhage 1 Breast Neoplasms 1

Interventions

telapristone acetate 7 vilaprisan 6 ulipristal acetate 3 Mifepristone 2 Bupivacaine 2 ulipristal 1 ferrous sulfate 1 epigallocatechin gallate 1 Vitamin B 6 1 Uterine Myomectomy 1 Tranexamic Acid 1 Tea 1 Sugars 1 Standard of Care 1 Radiofrequency Ablation 1 Pregabalin 1 Morphine 1 Misoprostol 1 Lidocaine 1 Leuprolide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02825719 2020-04-09

Ulipristal Use in Chinese Population

Queen Mary Hospital, Hong Kong

Phase 4 Terminated

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡